Norway Preclinical Cro Market Size & Outlook, 2026-2033
Related Markets
Norway preclinical cro market highlights
- The Norway preclinical cro market generated a revenue of USD 71.6 million in 2025 and is expected to reach USD 122.9 million by 2033.
- The Norway market is expected to grow at a CAGR of 7.3% from 2026 to 2033.
- In terms of segment, preclinical optimization, efficacy & pk/pd was the largest revenue generating development stage in 2025.
- Early CMC / Phase I–II Supply is the most lucrative development stage segment registering the fastest growth during the forecast period.
Preclinical cro market data book summary
| Market revenue in 2025 | USD 71.6 million |
| Market revenue in 2033 | USD 122.9 million |
| Growth rate | 7.3% (CAGR from 2026 to 2033) |
| Largest segment | Preclinical optimization, efficacy & pk/pd |
| Fastest growing segment | Early CMC / Phase I–II Supply |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Target Discovery, Preclinical Optimization, Efficacy & PK/PD, IND-Enabling Safety (GLP), Bioanalysis & Analytics, Early CMC / Phase I–II Supply |
| Key market players worldwide | Eurofins Scientific SE, Icon PLC, Wuxi AppTec Co Ltd, Medpace Holdings Inc, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Intertek Group PLC, Labcorp Holdings Inc, Crown Bioscience, SGA |
Other key industry trends
- In terms of revenue, Norway accounted for 1.1% of the global preclinical cro market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, UK preclinical cro market is projected to lead the regional market in terms of revenue in 2033.
- UK is the fastest growing regional market in Europe and is projected to reach USD 1,027.9 million by 2033.
Preclinical optimization, efficacy & pk/pd was the largest segment with a revenue share of 35.47% in 2025. Horizon Databook has segmented the Norway preclinical cro market based on target discovery, preclinical optimization, efficacy & pk/pd, ind-enabling safety (glp), bioanalysis & analytics, early cmc / phase i–ii supply covering the revenue growth of each sub-segment from 2021 to 2033.
The preclinical CRO market in Norway is expected to witness steady growth in the upcoming decade. Several global CROs have significant opportunities to enter the Norwegian market and expand their geographical footprint.
Some other factors contributing to market growth are networks/platforms for international cooperation, national initiatives (including trials), pilot projects, and infrastructure development. This factor is expected to create opportunities for clinical trials in Norway. There is a strong opportunity for several new entrants to enter and establish their presence in the country.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Preclinical CRO Market Scope
Preclinical CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| SGA | View profile | 11-50 | Las Condes, Region Metropolitana, Chile, South America | https://sgasa.cl |
| Crown Bioscience | View profile | 251-500 | Santa Clara, California, United States, North America | http://www.crownbio.com |
| Intertek Group PLC | View profile | 44000 | 33 Cavendish Square, London, United Kingdom, W1G 0PS | https://www.intertek.com |
| Medpace Holdings Inc | View profile | 5800 | 5375 Medpace Way, Cincinnati, OH, United States, 45227 | https://www.medpace.com |
| Wuxi AppTec Co Ltd | View profile | 41116 | 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai, China, People's Republic of, 200131 | https://www.wuxiapptec.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Labcorp Holdings Inc | View profile | 67000 | 358 South Main Street, Burlington, NC, United States, 27215 | https://www.labcorp.com |
| Charles River Laboratories International Inc | View profile | 21400 | 251 Ballardvale Street, Wilmington, MA, United States, 01887 | https://www.criver.com |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
Norway Development Stage - Preclinical Cro Market size, 2025 - 2033 (US$M)
Norway Preclinical CRO Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
